Neurocrine Biosciences Inc vs ZIM Integrated Shipping Services Ltd — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while ZIM Integrated Shipping Services Ltd trades at $24.92 (market cap $2.93B). The key difference: Neurocrine Biosciences Inc is far larger — about 5.9× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays a 20.16% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | ZIM | |
|---|---|---|
Market Cap | $17.40B | $2.93B |
Sector | Health | Industrials |
52-Week High | $180.55 | $29.27 |
52-Week Low | $123.10 | $12.44 |
Enterprise Value | $16.49B | $6.78B |
Dividend Yield | — | 20.16% |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →